Carcinogens, Mutagens and Reprotoxic Substances Directive

Learning objectives

On completion of this module, learners should be able to:

  • Explain the definitions of carcinogens, mutagens and reprotoxic substances (CMRs)
  • Outline the risks associated with working in an environment where exposure to CMRs may occur
  • Summarise the purpose of the carcinogens, mutagens and reprotoxic substances directive (CMRD)
  • Identify the 2022 updates and amendments to the CMRD
  • Elaborate on the key changes to the CMRD that will affect nurses and pharmacists
  • Outline how healthcare staff can prepare for the changes to the CMRD coming into force in 2024

 

Module 1 Carcinogens, Mutagens and Reprotoxic Substances Directive
Unit 1 Module
Unit 2 References
Unit 3 Assessment
Powered By WP Courseware

All educational content (including liaison with thought leaders) for the Safe Handling of Hazardous Drugs Hub has been initiated and produced by Cogora. Cogora is the publisher of Hospital Pharmacy Europe and Hospital Healthcare Europe, and conducts healthcare professional market insight activities globally. The Safe Handling of Hazardous Drugs Hub is funded by BD. However, BD has had no input or influence on either its content or the selection of contributors.